Cite
APA Citation
D'Haens, G., Danese, S., Davies, M., Watanabe, M., & Hibi, T. (n.d.). dOP48 Amiselimod, a selective S1P receptor modulator in Crohn's disease patients: a proof-of-concept study. Journal of Crohn's and colitis, 13, S055–S056. http://access.bl.uk/ark:/81055/vdc_100094055373.0x000011